➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Boehringer Ingelheim
Mallinckrodt
Merck
Colorcon

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Litigation Details for Merck Sharp & Dohme Corp. v. Xellia Pharmaceuticals ApS (D. Del. 2014)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Merck Sharp & Dohme Corp. v. Xellia Pharmaceuticals ApS (D. Del. 2014)

Docket   Start Trial Date Filed 2014-02-14
Court District Court, D. Delaware Date Terminated 2015-07-09
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties ALLEN M. -SM- TERRELL, JR.; MERCK SHARP & DOHME CORP.; XELLIA PHARMACEUTICALS APS; XELLIA PHARMACEUTICALS INC.
Patents 6,136,783
Attorneys Brian V. Slater; Carol M. Pitzel Cruz; Daniel R. Evans; Derek James Fahnestock; Jack B. Blumenfeld; Jeffrey D. Blake; Jeffrey S. Ward; Jeffrey Thomas Castellano; Karen Elizabeth Keller; Marcus A. Colucci; Stephen R. Howe; Wendy M. Ward; William R. Zimmerman
Firms Morris, Nichols, Arsht & Tunnell; Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Merck Sharp & Dohme Corp. v. Xellia Pharmaceuticals ApS
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Merck Sharp & Dohme Corp. v. Xellia Pharmaceuticals ApS (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-12-02 60 IV Certifications for U.S. Patent Nos. 5,952,300 and 6,136,783 with respect to ANDA No. 205923…-10-cv- 01625 (D.N.J.) 1-I U.S. Patent Application Publication No. 2012/0101030 … 2014 9 July 2015 1:14-cv-00199 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Johnson and Johnson
Merck
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.